Literature DB >> 18302839

Exhaled breath condensate pH in the evaluation of asthma.

Christopher Coop1, Larry L Hagan, John P Dice.   

Abstract

As a marker of inflammation, exhaled breath condensate (EBC) pH may be a useful screening tool in the evaluation of asthma, especially in a military recruit population. To evaluate the utility of EBC pH in the diagnosis of asthma, EBC pH levels were determined in basic military trainees prior to an evaluation for asthma that included a history, physical exam, baseline spirometry, and a methacholine or exercise challenge. Of 86 basic trainees who had symptoms suggestive of asthma and underwent methacholine or exercise challenges, 51 (59.3%) had a positive methacholine or exercise challenge and were diagnosed with asthma. The mean EBC pH of the trainees who were diagnosed with asthma (6.39, range 5.91-6.82), was significantly (p < 0.001) lower than those trainees without asthma (6.64, range 6.34-7.18). There was, however, some overlap of the EBC pH values between the two groups. The measurement of EBC pH did show a significant mean difference between asthmatic and nonasthmatic patients in a military recruit population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18302839     DOI: 10.2500/aap2008.29.3073

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  2 in total

1.  Determinants of exhaled breath condensate pH in a large population with asthma.

Authors:  Lei Liu; W Gerald Teague; Serpil Erzurum; Anne Fitzpatrick; Sneha Mantri; Raed A Dweik; Eugene R Bleecker; Deborah Meyers; William W Busse; William J Calhoun; Mario Castro; Kian Fan Chung; Douglas Curran-Everett; Elliot Israel; W Nizar Jarjour; Wendy Moore; Stephen P Peters; Sally Wenzel; John F Hunt; Benjamin Gaston
Journal:  Chest       Date:  2010-10-21       Impact factor: 9.410

Review 2.  Breath tests in respiratory and critical care medicine: from research to practice in current perspectives.

Authors:  Attapon Cheepsattayakorn; Ruangrong Cheepsattayakorn
Journal:  Biomed Res Int       Date:  2013-09-18       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.